ISSN 2996-8968
Vol. 3, Issue 3, 2026September 29, 2026 EDT
Immunogenicity in Cancer Nanomedicine
Immunogenicity in Cancer Nanomedicine
Aliyu Hussaini, Abba Musa, Huzaifa Abdullahi, Muhammad Amiru Aliyu, Arif Aliyu Abbas, Harisu Mikailu, Fatima Bashir Alkali, Kingsley Enuma,
pharmaceutical excipientscancer nanomedicinepolyethyleneglycolanti-PEG antibodiesrepeat dosinglipid nanoparticles
Articles in Vol. 3, Issue 3, 2026
Vol. 3, Issue 3, 2026
- Immunogenicity in Cancer NanomedicineAliyu HussainiAbba MusaHuzaifa AbdullahiMuhammad Amiru AliyuArif Aliyu AbbasHarisu MikailuFatima Bashir AlkaliKingsley Enuma
- Modified Banana Starch: A Promising Pharmaceutical Disintegrant for the FutureSupriya SandhanSurabhi PatilMahesh HarishchandreMilind WaghKirti Patil
- Impact of polyethylene glycol polymer source variations on the performance of long-acting injectable suspensionsNilesh MalaviaSaurabh BadoleMelissa SabatellaQuanying BaoDiane J. Burgess
- Eco-Friendly Solvents and Excipients in Pharmaceutical DevelopmentHarika NaganaboinaSailaja GunnamMonika NijhawanSeetha DevVRS Anusha
Hussaini, Aliyu, Abba Musa, Huzaifa Abdullahi, Muhammad Amiru Aliyu, Arif Aliyu Abbas, Harisu Mikailu, Fatima Bashir Alkali, and Kingsley Enuma. 2026. “Immunogenicity in Cancer Nanomedicine.” International Journal of Pharmaceutical Excipients 3 (3): 272–83.